Automated Genomic Data Ingestion and Quality Control Workflow

Specialized agents automatically ingest raw FASTQ/BAM files from diverse sources—lab sequencers (Illumina, PacBio), cloud storage (AWS S3, GCP), and public repositories (NCBI SRA). Each agent validates file integrity (MD5 checks), extracts critical metadata (instrument, run ID, sample barcodes), and logs the transaction in the LIMS (e.g., Benchling, LabVantage). This replaces manual file transfers and spreadsheet tracking, preventing sample misidentification and data loss from the point of generation.

Upon ingestion, an orchestrated QC pipeline is triggered using tools like FastQC and MultiQC. Autonomous agents analyze key metrics—read quality (Q-score distribution), adapter content, GC bias, and sequence duplication levels. A separate screening module uses k-mer analysis (e.g., Kraken2) to flag microbial or cross-species contamination. Samples failing thresholds are automatically routed to a 'Requires Review' queue in the LIMS, with alerts sent to lab technicians for potential re-sequencing, preventing costly downstream analysis errors.

The core workflow is managed by an orchestration framework (e.g., LangGraph, Nextflow) that defines the state machine for data progression. It coordinates preprocessing tasks: read trimming (Trimmomatic), alignment to a reference genome (BWA-MEM), and sorting/indexing (samtools). The engine manages compute resource allocation on cloud/HPC clusters, handles job failures with automatic retries, and updates the central data catalog. This turns a fragile, script-based process into a fault-tolerant, auditable production system.

A critical integration layer maintains bidirectional sync between the automated workflow and enterprise systems. Using a combination of REST APIs and browser automation for legacy LIMS, it pushes QC reports, processed file locations (e.g., BAM paths in S3), and status updates. It also pulls sample metadata and project context to inform processing parameters. This hub creates a single source of truth, eliminating silos between wet-lab operations, bioinformatics, and data science teams.

Not all processes can be fully autonomous. The architecture includes defined approval gates for exceptions: low-quality samples, ambiguous metadata, or suspected contamination. These cases are routed via Slack/MS Teams alerts or tickets in Jira/ServiceNow to designated bioinformaticians or lab managers. Their decisions (e.g., 'proceed with flag,' 'rerun,' 'discard') are captured as audit trails and fed back into the workflow to close the loop, ensuring scientific rigor and operational control.

The entire workflow is instrumented for observability. Metrics on ingestion latency, QC pass/fail rates, compute cost per sample (from cloud providers), and pipeline success rates are streamed to dashboards (Grafana). Every action—from file upload to analyst decision—is logged with full provenance for regulatory compliance and internal audit. This visibility allows continuous optimization of the workflow for speed, cost, and quality, turning data operations into a measurable, managed asset.

Primary Beneficiaries & Key Implementers. They gain 40-60% time savings by eliminating manual file wrangling, script babysitting, and basic QC checks. The workflow automates data validation, contamination flagging, and preprocessing, allowing them to focus on high-value analysis like variant discovery and trait modeling. Their involvement is critical for defining QC thresholds, selecting tools (FastQC, MultiQC), and validating the automated pipeline's outputs against manual benchmarks.

Operational Beneficiaries & Data Source Owners. They benefit from automated run monitoring and proactive failure alerts, preventing the loss of expensive sequencing runs. The workflow integrates with LIMS (e.g., Benchling, LabVantage) and sequencer APIs (Illumina, PacBio), automatically logging sample metadata and capturing run metrics. Their involvement ensures the ingestion layer correctly handles diverse file formats and instrument outputs, reducing manual data entry errors and improving lab throughput.

Strategic Beneficiaries of Data Quality. They rely on clean, analysis-ready genomic data to make confident selection and advancement decisions. The workflow's automated QC gates ensure that only high-integrity data flows into downstream genomic prediction and GWAS pipelines, directly improving the accuracy of breeding values and trait associations. Their involvement is in defining the 'good enough for decision-making' quality standards and prioritizing which data streams (e.g., WGS vs. GBS) to automate first.

Enablers of Scalable Architecture. They are responsible for implementing the orchestration layer (e.g., using Nextflow, Snakemake, or LangGraph) on scalable cloud/HPC infrastructure (AWS Batch, Google Cloud Life Sciences). Their value is in building a fault-tolerant, cost-optimized system that can handle petabyte-scale data ingestion. They define the CI/CD pipeline for bioinformatics tools, manage resource allocation, and implement the monitoring and alerting stack (e.g., Datadog, Prometheus) for pipeline health.

Governance Stakeholders. They benefit from automated audit trails and provenance tracking that meets GLP and internal reproducibility standards. The workflow must log every data transformation, tool version, and QC parameter, creating an immutable record for regulatory submissions (e.g., to USDA-APHIS for biotech traits). Their involvement ensures the system design includes necessary data versioning, access controls, and documentation for defensible science.

Economic Decision-Makers. They fund the build to accelerate the entire R&D pipeline and protect the value of the genomic data asset. The ROI for them comes from reducing experimental cycle times, preventing costly downstream errors from poor data, and increasing the throughput of candidate lines. Their involvement is in approving the build vs. buy decision, prioritizing use cases, and measuring the operational impact on project timelines and resource allocation.